Treating pigment in higher Fitzpatrick phototypes has long been a concern clinics decline. Dr Tego Kirnon-Jackman explains what changed, and why technology should be chosen by target rather than by novelty Every technology decision in a clinic comes down to …
Subscriber content
Continue reading this clinical article
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in
